相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
Pamela C. Rosato et al.
NATURE COMMUNICATIONS (2019)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Immunogenic neoantigens derived from gene fusions stimulate T cell responses
Wei Yang et al.
NATURE MEDICINE (2019)
Mass spectrometry based identification of MHC-bound peptides for immunopeptidomics
Anthony W. Purcell et al.
NATURE PROTOCOLS (2019)
Induction of neoantigen-reactive T cells from healthy donors
Muhammad Ali et al.
NATURE PROTOCOLS (2019)
The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells
Laura Santambrogio et al.
FRONTIERS IN IMMUNOLOGY (2019)
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
Tomasz Kula et al.
CELL (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Developing neoantigen-targeted T cell-based treatments for solid tumors
Tori N. Yamamoto et al.
NATURE MEDICINE (2019)
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
Lee P. Richman et al.
CELL SYSTEMS (2019)
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Alice Newey et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival
Jing Zhang et al.
COMMUNICATIONS BIOLOGY (2019)
Population-level distribution and putative immunogenicity of cancer neoepitopes
Mary A. Wood et al.
BMC CANCER (2018)
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Marvin H. Gee et al.
CELL (2018)
T cells specific for post-translational modifications escape intrathymic tolerance induction
Bruno Raposo et al.
NATURE COMMUNICATIONS (2018)
A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens
Zhuting Hu et al.
BLOOD (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens
Luisa Escobar Hoyos et al.
CANCER CELL (2018)
The Partnership for Accelerating Cancer Therapies
Rebecca G. Baker et al.
CANCER JOURNAL (2018)
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding
Leah V. Sibener et al.
CELL (2018)
Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts
Victor G. Wang et al.
PLOS ONE (2018)
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma (vol 24, pg 1545, 2018)
Noam Auslander et al.
NATURE MEDICINE (2018)
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer
Heather L. Kinkead et al.
JCI INSIGHT (2018)
Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors
Kazuma Kiyotani et al.
JOURNAL OF HUMAN GENETICS (2017)
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
Meng Michelle Xu et al.
IMMUNITY (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
Lawrence J. Jennings et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic et al.
LANCET ONCOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Quantifiable predictive features define epitope-specific T cell receptor repertoires
Pradyot Dash et al.
NATURE (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Luksza et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro
Thomas M. Schmitt et al.
NATURE BIOTECHNOLOGY (2017)
The problem with neoantigen prediction
NATURE BIOTECHNOLOGY (2017)
Fast and accurate HLA typing from short-read next-generation sequence data with xHLA
Chao Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Neoantigen Vaccines Pass the Immunogenicity Test
Gerald P. Linette et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Precision Oncology: The Road Ahead
Daniela Senft et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Stacy A. Malaker et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
Eva Braeunlein et al.
FRONTIERS IN IMMUNOLOGY (2017)
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
Mirjana Efremova et al.
FRONTIERS IN IMMUNOLOGY (2017)
Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity
Qingyu Wang et al.
SCIENTIFIC REPORTS (2017)
MHC-I Genotype Restricts the Oncogenic Mutational Landscape
Rachel Marty et al.
CELL (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Eric Tran et al.
NATURE IMMUNOLOGY (2017)
Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo
Aude G. Chapuis et al.
SCIENCE IMMUNOLOGY (2017)
Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
Abderraouf Selmi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Vaccine adjuvants as potential cancer immunotherapeutics
Burcu Temizoz et al.
INTERNATIONAL IMMUNOLOGY (2016)
Immunotherapy: Cancer vaccine triggers antiviral-type defences
Jolanda De Vries et al.
NATURE (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Rekindling cancer vaccines
Malorye Allison Branca
NATURE BIOTECHNOLOGY (2016)
Prospects for gene-engineered T cell immunotherapy for solid cancers
Christopher A. Klebanoff et al.
NATURE MEDICINE (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Stefani Spranger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function
Kuntal Worah et al.
CELL REPORTS (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis et al.
CELL REPORTS (2016)
A Survey of Computational Tools to Analyze and Interpret Whole Exome Sequencing Data
Jennifer D. Hintzsche et al.
INTERNATIONAL JOURNAL OF GENOMICS (2016)
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+ T cell recognition
Kirsteen M. Tullett et al.
JCI INSIGHT (2016)
VarDict: A novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
CANCER RESEARCH (2015)
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies
Thomas M. Schmitt et al.
CLINICAL CANCER RESEARCH (2015)
Immunogenic peptide discovery in cancer genomes
Alexandra Snyder et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity
Jennifer D. Stone et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
Matthias Obenaus et al.
NATURE BIOTECHNOLOGY (2015)
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Sachet A. Shukla et al.
NATURE BIOTECHNOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
Tyler S. Alioto et al.
NATURE COMMUNICATIONS (2015)
Performance comparison of four commercial human whole-exome capture platforms
Daichi Shigemizu et al.
SCIENTIFIC REPORTS (2015)
Exome Sequencing: Current and Future Perspectives
Amanda Warr et al.
G3-GENES GENOMES GENETICS (2015)
HLAreporter: a tool for HLA typing from next generation sequencing data
Yazhi Huang et al.
GENOME MEDICINE (2015)
Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
Enric Gutierrez-Martinez et al.
FRONTIERS IN IMMUNOLOGY (2015)
OptiType: precision HLA typing from next-generation sequencing data
Andras Szolek et al.
BIOINFORMATICS (2014)
Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads
Yu Bai et al.
BMC GENOMICS (2014)
Performance comparison of four exome capture systems for deep sequencing
Chandra Sekhar Reddy Chilamakuri et al.
BMC GENOMICS (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming
Marc Dalod et al.
EMBO JOURNAL (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Detailed comparison of two popular variant calling packages for exome and targeted exon studies
Charles D. Warden et al.
PEERJ (2014)
Human dendritic cell functional specialization in steady-state and inflammation
Arian Boltjes et al.
FRONTIERS IN IMMUNOLOGY (2014)
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)
Ludger Klein et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Experimental models to investigate the function of dendritic cell subsets: challenges and implications
D. G. Hancock et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
HLA Haplotyping from RNA-seq Data Using Hierarchical Read Weighting
Hyunsung John Kim et al.
PLOS ONE (2013)
Sequencing quality assessment tools to enable data-driven informatics for high throughput genomics
Richard M. Leggett et al.
Frontiers in Genetics (2013)
SomaticSniper: identification of somatic point mutations in whole genome sequencing data
David E. Larson et al.
BIOINFORMATICS (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A fast and accurate SNP detection algorithm for next-generation sequencing data
Feng Xu et al.
NATURE COMMUNICATIONS (2012)
HLA typing from RNA-Seq sequence reads
Sebastian Boegel et al.
GENOME MEDICINE (2012)
Derivation of HLA types from shotgun sequence datasets
Rene L. Warren et al.
GENOME MEDICINE (2012)
Engineering Dendritic Cells to Enhance Cancer Immunotherapy
Jeanette E. Boudreau et al.
MOLECULAR THERAPY (2011)
Performance comparison of exome DNA sequencing technologies
Michael J. Clark et al.
NATURE BIOTECHNOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
MHC Class II epitope predictive algorithms
Morten Nielsen et al.
IMMUNOLOGY (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain
Juergen Kuball et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers
Yvette Schwitalle et al.
GASTROENTEROLOGY (2008)
Class II major histocompatibility complex tetramer staining: progress, problems, and prospects
Sabrina S. Vollers et al.
IMMUNOLOGY (2008)
Design and use of conditional MHC class I ligands
M Toebes et al.
NATURE MEDICINE (2006)
Post-translational modifications of naturally processed MHC-binding epitopes
VH Engelhard et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Generation of peptide-MHC class I complexes through UV-mediated ligand exchange
Boris Rodenko et al.
NATURE PROTOCOLS (2006)
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA
B Scheel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm
RJ Duquesnoy
HUMAN IMMUNOLOGY (2002)
Dendritic cells: Specialized and regulated antigen processing machines
I Mellman et al.
CELL (2001)
Post-translational protein modifications in antigen recognition and autoimmunity
HA Doyle et al.
TRENDS IN IMMUNOLOGY (2001)
Dendritic cells: Immunological sentinels with a central role in health and disease
LH Stockwin et al.
IMMUNOLOGY AND CELL BIOLOGY (2000)
分享论文
